Research Article

Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound

Volume: 47 Number: 3 June 29, 2026

Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound

Abstract

Sulfonamide compounds with the RSO2NH2 structure, by modifying the R group to heterocyclic, aromatic or aliphatic, are found in many drugs with a wide range of chemical, physical, and biological properties, including antiviral, diuretic, antibacterial, anticancer, hypoglycemic, and antifungal properties. Sulfonamide-1,2,3-triazole hybrid represent a class of compounds with significant potential in medicinal chemistry due to their versatile biological activities. In this study, novel sulfonamide–triazole derivative was synthesized via Cu(I)-catalyzed azide–alkyne cycloaddition click reaction. The compound was characterized by spectroscopic techniques. DNA binding studies on fish DNA sperm and molecular docking studies were performed on the synthesized compound. DNA-binding studies, including UV-Vis titration and fluorescence spectroscopy indicated predominant minor groove binding, with 4-methyl-N-((1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl)methyl)benzenesulfonamide (2)  showing the affinity (Kb = 4.9 × 10⁴ M⁻¹) parameters. Molecular docking of compound (2) demonstrated strong binding interactions with DNA consistent with experimental results. Docking studies for compound 2 indicated good oral bioavailability, low toxicity, and favorable pharmacokinetic properties. These findings highlight compound 2 as a promising drug-like candidate for further biological evaluation.

Keywords

DNA binding, Molecular docking, Sulfa drug, 1, 2, 3-Triazole hybrids

Supporting Institution

This study did not receive any support.

Ethical Statement

There is no application in this study that would require an ethics committee decision.

Thanks

This study does not contain any section requiring acknowledgements.

References

  1. He, S. C., Zhang, H. Z., Zhang, H. J., Sun, Q., & Zhou, C. H. (2020). Design and synthesis of novel sulfonamide-derived triazoles and bioactivity exploration. Medicinal Chemistry, 16(1), 104-118. https://doi.org/10.2174/1573406414666181106124852.
  2. Lin, J., Zhou, S., Xu, J. X., Yao, W. Q., Hao, G. F., & Li, Y. T. (2020). Design, synthesis, and structure–activity relationship of economical triazole sulfonamide aryl derivatives with high fungicidal activity. Journal of Agricultural and Food Chemistry, 68(25), 6792-6801. https://doi.org/10.1021/acs.jafc.9b07887.
  3. Kaushik, C. P., Chahal, M., Luxmi, R., Kumar, D., Kumar, A., Kumar, M., & Singh, D. (2020). Synthesis, characterization and biological activities of sulfonamide tagged 1, 2, 3-triazoles. Synthetic Communications, 50(22), 3443-3461. https://doi.org/10.1080/00397911.2020.1802758.
  4. Tietz, V. C., Ortale, M. L., das Neves, A. R., Pelizaro, B. I., Carvalho, D. B., Shiguemoto, C. Y., ... & Baroni, A. C. (2025). Design and Synthesis of 2‐Nitroimidazole‐1, 2, 3‐triazole Sulfonamide Hybrids as Potent and Selective Anti‐Trypanosomatid Agents. ChemMedChem, 20(5), e202400516. https://doi.org/10.1002/cmdc.202400516.
  5. Supuran, C. T., Innocenti, A., Mastrolorenzo, A., & Scozzafava, A. (2004). Antiviral sulfonamide derivatives. Mini reviews in medicinal chemistry, 4(2), 189-200.
  6. Moskalik, M. Y. (2022). Sulfonamides with heterocyclic periphery as antiviral agents. Molecules, 28(1), 51. https://doi.org/10.3390/molecules28010051.
  7. Chalkha, M., Nakkabi, A., Hadda, T. B., Berredjem, M., El Moussaoui, A., Bakhouch, M., ... & El Yazidi, M. (2022). Crystallographic study, biological assessment and POM/Docking studies of pyrazoles-sulfonamide hybrids (PSH): Identification of a combined Antibacterial/Antiviral pharmacophore sites leading to in-silico screening the anti-Covid-19 activity. Journal of Molecular Structure, 1267, 133605. https://doi.org/10.1016/j.molstruc.2022.133605.
  8. Ovung, A., & Bhattacharyya, J. (2021). Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions. Biophysical reviews, 13(2), 259-272. https://doi.org/10.1007/s12551-021-00795-9.
  9. Ueda, Y., Miyazaki, M., Mashima, K., Takagi, S., Hara, S., Kamimura, H., & Jimi, S. (2020). The effects of silver sulfadiazine on methicillin-resistant Staphylococcus aureus biofilms. Microorganisms, 8(10), 1551. https://doi.org/10.3390/microorganisms8101551.
  10. Kamal, A., Shankaraiah, N., Devaiah, V., Reddy, K. L., Juvekar, A., Sen, S., ... & Zingde, S. (2008). Synthesis of 1, 2, 3-triazole-linked pyrrolobenzodiazepine conjugates employing 'click'chemistry: DNA-binding affinity and anticancer activity. Bioorganic & Medicinal Chemistry Letters, 18(4), 1468-1473. https://doi.org/10.1016/j.bmcl.2007.12.063.
APA
Albayrak Mısır, B. (2026). Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound. Cumhuriyet Science Journal, 47(3), 504-513. https://doi.org/10.17776/csj.1823568
AMA
1.Albayrak Mısır B. Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound. CSJ. 2026;47(3):504-513. doi:10.17776/csj.1823568
Chicago
Albayrak Mısır, Büşra. 2026. “Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound”. Cumhuriyet Science Journal 47 (3): 504-13. https://doi.org/10.17776/csj.1823568.
EndNote
Albayrak Mısır B (June 1, 2026) Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound. Cumhuriyet Science Journal 47 3 504–513.
IEEE
[1]B. Albayrak Mısır, “Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound”, CSJ, vol. 47, no. 3, pp. 504–513, June 2026, doi: 10.17776/csj.1823568.
ISNAD
Albayrak Mısır, Büşra. “Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound”. Cumhuriyet Science Journal 47/3 (June 1, 2026): 504-513. https://doi.org/10.17776/csj.1823568.
JAMA
1.Albayrak Mısır B. Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound. CSJ. 2026;47:504–513.
MLA
Albayrak Mısır, Büşra. “Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound”. Cumhuriyet Science Journal, vol. 47, no. 3, June 2026, pp. 504-13, doi:10.17776/csj.1823568.
Vancouver
1.Büşra Albayrak Mısır. Synthesis, DNA Binding and Molecular Docking Studies of Sulfonamide-Triazole Hybrid Compound. CSJ. 2026 Jun. 1;47(3):504-13. doi:10.17776/csj.1823568